Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets

Mult Scler Relat Disord. 2020 Nov:46:102469. doi: 10.1016/j.msard.2020.102469. Epub 2020 Aug 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / complications
  • COVID-19 / virology
  • COVID-19 Drug Treatment*
  • Cladribine / pharmacology*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacology*
  • Multiple Sclerosis / complications*
  • Multiple Sclerosis / drug therapy
  • Multiple Sclerosis / virology*
  • SARS-CoV-2 / drug effects
  • SARS-CoV-2 / pathogenicity*
  • Tablets / pharmacology

Substances

  • Immunosuppressive Agents
  • Tablets
  • Cladribine